Clinical Trial Update: A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating erythropoietin B for hematopoietic response in anemic patients with hematologic malignancies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Erythropoietin B (erythropoietin B)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: TERMINATED